MISSISSAUGA, ON, Feb. 28,
2023 /CNW/ - Covalon Technologies Ltd. (the "Company"
or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical
technologies company, has announced that the annual and special
meeting of shareholders of the Company will be held on Wednesday, March 8, 2023 at 3:30pm EST in a virtual-only format where
shareholders may attend and participate in the meeting via live
webcast.
Registered shareholders and duly appointed proxyholders will be
able to attend, participate, and vote at the Meeting online at
https://virtual-meetings.tsxtrust.com/1416, Meeting ID being 1416,
using Password "covalon2023" (case sensitive).
If you are a non-registered Shareholder (shareholder who holds
their shares through a broker, investment dealer, bank, trust
company, custodian, nominee, or other intermediary) and want to
vote online at the Meeting, you must appoint yourself as
proxyholder and register with TSX Trust Company in advance of the
Meeting by emailing tsxtrustproxyvoting@tmx.com the "Request for
Control Number" form, which can be found here
https://tsxtrust.com/resource/en/75. Registering your proxyholder
is an additional step to be completed AFTER you have submitted your
form of proxy or voting instruction form.
Non-registered shareholders who have not duly appointed
themselves as proxyholder will not be able to vote at the Meeting
but will be able to attend the Meeting as guests.
Guests are invited to attend the meeting by navigating to
https://virtual-meetings.tsxtrust.com/1416, Meeting ID being 1416,
and clicking on "I am a Guest".
Copies of Covalon's Management Information Circular, financial
statements, and MD&A can be obtained on SEDAR at www.sedar.com
and under Sedar Filings on the Investors tab of Covalon's
website.
For those interested in learning more about Covalon's solutions,
visit www.covalon.com or follow Covalon on LinkedIn, Facebook,
Instagram or Twitter.
About Covalon
Covalon Technologies Ltd. is a patient-driven medical device
company, built on the relentless pursuit to help the most
vulnerable patients have a better chance at healing. Through a
strong portfolio of patented technologies and solutions for
advanced wound care, infection prevention, and medical device
coatings, we offer innovative, gentler, and more compassionate
options for patients to heal with less infections, less pain, and
better outcomes. Our solutions are designed for patients and made
for care providers. Covalon leverages its patented medical
technology platforms and expertise in two ways: (i) by developing
products that are sold under Covalon's name; and (ii) by developing
and commercializing medical products for other medical companies
under development and license contracts. The Company is listed on
the TSX Venture Exchange, having the symbol COV and trades on the
OTCQX Market under the symbol CVALF. To learn more about Covalon,
visit our website at www.covalon.com.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
This news release may contain forward-looking statements
which reflect the Company's current expectations regarding future
events. The forward-looking statements are often, but not always,
identified by the use of words such as "seek", "anticipate", "plan,
"estimate", "expect", "intend", or variations of such words and
phrases or state that certain actions, events, or results "may",
"could", "would", "might", "will" or "will be taken", "occur", or
"be achieved". In addition, any statements that refer to
expectations, projections, or other characterizations of future
events or circumstances contain forward-looking information.
Statements containing forward-looking information are not
historical facts, but instead represent management's expectations,
estimates, and projections regarding future events. Forward-looking
statements involve risks and uncertainties, including, but not
limited to, the factors described in greater detail in the "Risks
and Uncertainties" section of our management's discussion and
analysis of financial condition and results of operations for the
three months ended December 31, 2022,
which is available on the Company's profile at
www.sedar.com, any of which could cause results,
performance, or achievements to differ materially from the results
discussed or implied in the forward-looking statements. Investors
should not place undue reliance on any forward-looking statements.
The forward-looking statements contained in this news release are
made as of the date of this news release, and the Company assumes
no obligation to update or alter any forward-looking statements,
whether as a result of new information, further events, or
otherwise, except as required by law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/covalon-to-hold-annual-and-special-meeting-of-shareholders-on-wednesday-march-8-2023-301757568.html
SOURCE Covalon Technologies Ltd.